PMC full text: | Published online 2016 Jan 5. doi: 10.1371/journal.pone.0145720
|
Age year | Number of Subject | Number of Positive Samples (%) Peptides testeda | |||
---|---|---|---|---|---|
Tag A | Tag D | Tag (A+D) | hNPS | ||
18–30 | 88 | 32 (36) | 28 (32) | 25 (28)* | 0 (0) |
31–40 | 171 | 38 (22) | 49 (29) | 35 (20) | 0 (0) |
41–50 | 255 | 60 (24) | 61 (24) | 49 (19) | 0 (0) |
51–65 | 190 | 36 (19) | 31 (16) | 29 (15)* | 0 (0) |
Total | 704 | 166 (24) | 169 (24) | 138 (20) | 0 (0) |
Human sera were from healthy subjects. Statistical analysis was performed using the Chi-square test with Yates’ correction. The difference in prevalence of SV40 antibodies between the cohorts of individuals aged 18–30 years old and 51–65 years old was statistically significant (*P < 0.05).
aTag A = SV40 T antigen mimotope A; Tag D = SV40 T antigen mimotope D
hNPS = human neuropeptide S.